Influence of the Microenvironment on Melanoma Cell Fate Determination and Phenotype
Open Access
- 15 August 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (16) , 7833-7836
- https://doi.org/10.1158/0008-5472.can-06-0731
Abstract
Tumor cells communicate bidirectionally with the surrounding microenvironment, sending and receiving topographical and molecular cues that direct diverse cellular phenomena, including differentiation, growth, and invasion. The microenvironment has long been acknowledged as a facilitator of melanoma progression, and recent studies have illuminated tumor-associated factors, including hypoxia and the extracellular matrix, as important mediators of melanocyte transformation and transdifferentiation. Although these findings portray the microenvironment as a perilous obstacle to the successful treatment of advanced melanomas, it is important to note that certain molecular milieus may be capitalized on as potential treatment modalities. Indeed, our group and others have elucidated the unique ability of embryonic microenvironments to normalize aggressive melanoma cells toward a more benign melanocytic phenotype. The microenvironment therefore presents a novel target for the treatment and ultimately the prevention of melanoma progression and metastasis. (Cancer Res 2006; 66(16): 7833-6)Keywords
This publication has 19 references indexed in Scilit:
- Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi's Sarcoma: An AIDS Malignancy Consortium StudyJournal of Clinical Oncology, 2006
- Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by HypoxiaCancer Research, 2005
- A Three-Dimensional Model to Study the Epigenetic Effects Induced by the Microenvironment of Human Embryonic Stem CellsThe International Journal of Cell Cloning, 2005
- Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma MicroenvironmentCancer Research, 2005
- Use of human tissue to assess the oncogenic activity of melanoma-associated mutationsNature Genetics, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Reprogramming of a melanoma genome by nuclear transplantationGenes & Development, 2004
- Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to MelanomasCancer Research, 2004
- Focus on melanomaCancer Cell, 2002
- Reversible sideroblastic anemia associated with the tetracycline analogue COL‐3American Journal of Hematology, 2001